The latest closing stock price for Barinthus Biotherapeutics as of September 18, 2024 is 1.23.
An investor who bought $1,000 worth of Barinthus Biotherapeutics stock at the IPO in 2021 would have $-913 today, roughly -1 times their original investment - a -55.69% compound annual growth rate over 3 years.
The all-time high Barinthus Biotherapeutics stock closing price was 17.00 on May 17, 2021.
The Barinthus Biotherapeutics 52-week high stock price is 5.10, which is 314.6% above the current share price.
The Barinthus Biotherapeutics 52-week low stock price is 1.11, which is 9.8% below the current share price.
The average Barinthus Biotherapeutics stock price for the last 52 weeks is 2.49.
An investor who bought $1,000 worth of Barinthus Biotherapeutics stock at the IPO in 2021 would have $-913 today, roughly -1 times their original investment - a -55.69% compound annual growth rate over 3 years.
The all-time high Barinthus Biotherapeutics stock closing price was 17.00 on May 17, 2021.
The Barinthus Biotherapeutics 52-week high stock price is 5.10, which is 314.6% above the current share price.
The Barinthus Biotherapeutics 52-week low stock price is 1.11, which is 9.8% below the current share price.
The average Barinthus Biotherapeutics stock price for the last 52 weeks is 2.49.